Lucid Vermögensrendite
Was ist das Vermögensrendite von Lucid?
Vermögensrendite von Lucid, Inc. ist -174.77%
Was ist die Definition von Vermögensrendite?
Die Vermögensrendite gibt an, wie rentabel die Vermögenswerte eines Unternehmens bei der Erzielung von Einnahmen sind. Sie wird berechnet, indem das Nettoeinkommen durch die durchschnittliche Bilanzsumme geteilt wird.
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Vermögensrendite von Unternehmen in Health Care Sektor auf OTC im Vergleich zu Lucid
Was macht Lucid?
Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging. It also offers VivaScan software to schedule patients for examinations, perform imaging examinations on one or more lesions during a visit, review, and report on images obtained during an examination, as well as VivaNet, a digital telepathology system. The company was formerly known as Lucid, Inc. and changed its name to Caliber Imaging & Diagnostics, Inc. in August 2012. Caliber Imaging & Diagnostics, Inc. was founded in 1991 and is headquartered in Andover, Massachusetts.
Unternehmen mit vermögensrendite ähnlich Lucid
- Hank Payments hat Vermögensrendite von -178.17%
- Adveritas hat Vermögensrendite von -177.51%
- Rhinomed hat Vermögensrendite von -176.99%
- Mydecine Innovations hat Vermögensrendite von -176.15%
- Achiko AG hat Vermögensrendite von -175.93%
- Power Projects hat Vermögensrendite von -174.85%
- Lucid hat Vermögensrendite von -174.77%
- Biostage hat Vermögensrendite von -174.42%
- Hepion Pharmaceuticals Inc hat Vermögensrendite von -174.30%
- Bankers Cobalt Corp hat Vermögensrendite von -174.28%
- LawFinance hat Vermögensrendite von -174.20%
- Pathway Health Corp hat Vermögensrendite von -173.40%
- Harvest Technology hat Vermögensrendite von -172.87%